On February 4, 2016, Noubar Afeyan, Ph.D. notified BG Medicine, Inc. that he was resigning from the Company's Board of Directors, effective as of that date. On February 4, 2016, the Board appointed Jeffrey R. Luber, JD, MBA, to join the Board to serve as a Class I director until the 2018 Annual Meeting of Stockholders and until his successor has been duly elected and qualified, or until his earlier resignation, retirement, removal or death. The Board also appointed Mr. Luber to the Audit Committee.